These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10204370)

  • 41. Medicinal herbs: a primer for primary care.
    Hadley SK; Petry JJ
    Hosp Pract (1995); 1999 Jun; 34(6):105-6, 109-12, 115-6 passim. PubMed ID: 10386114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ginkgo extract helps patients suffering from tinnitus. Review of the literature shows: tinnitus decreases].
    Holstein N
    MMW Fortschr Med; 2000 Nov; 142(47):46. PubMed ID: 11143781
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of ginkgo biloba extract on impairment of learning induced by cerebral ischemia in mice.
    Tadano T; Nakagawasai O; Tan-no K; Morikawa Y; Takahashi N; Kisara K
    Am J Chin Med; 1998; 26(2):127-32. PubMed ID: 9799964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can ginkgo biloba dust off mental cobwebs?
    Pa Med; 2001; 104(2):23. PubMed ID: 11307670
    [No Abstract]   [Full Text] [Related]  

  • 45. Can winter depression be prevented by Ginkgo biloba extract? A placebo-controlled trial.
    Lingaerde O; Føreland AR; Magnusson A
    Acta Psychiatr Scand; 1999 Jul; 100(1):62-6. PubMed ID: 10442441
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Preliminary assessment of ginkgo biloba (Ginkofar) in patients with dementia].
    Bidzan L; Biliekiewicz A; Turczyński J
    Psychiatr Pol; 2005; 39(3):559-66. PubMed ID: 16149765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of Ginkgo-biloba extract on mental performance. Double-blind study using computerized measurement conditions in patients with cerebral insufficiency].
    Grässel E
    Fortschr Med; 1992 Feb; 110(5):73-6. PubMed ID: 1544615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of patients with chronic cerebral ischemia: experience of using the combined neuroprotective drug Picamilon Ginkgo].
    Zakharov VV; Borodulina IV; Vakhnina NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):95-103. PubMed ID: 36168693
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Extract of Ginkgo biloba in glaucoma].
    Stefan C; Pop A; Cojocaru I
    Oftalmologia; 2011; 55(1):27-9. PubMed ID: 21774382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preliminary results in the modifications of cerebral blood flow using xenon-133 during administration of ginkgo-biloba].
    Agnoli A; Fiorani P; Pistolese GR
    Minerva Med; 1973 Nov; 64(79 Suppl):4166-73. PubMed ID: 4378392
    [No Abstract]   [Full Text] [Related]  

  • 51. Ginkgo biloba: a living fossil.
    Jacobs BP; Browner WS
    Am J Med; 2000 Mar; 108(4):341-2. PubMed ID: 11014729
    [No Abstract]   [Full Text] [Related]  

  • 52. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer's disease.
    Zimmermann M; Colciaghi F; Cattabeni F; Di Luca M
    Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):613-23. PubMed ID: 12396071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of tanakan in disturbances of memory and attention in the elderly].
    Zakharov VV
    Ter Arkh; 2002; 74(12):95-100. PubMed ID: 12577855
    [No Abstract]   [Full Text] [Related]  

  • 54. [The effect of tanakan on central nervous system function in patients with the residual manifestations of stroke].
    Kuznetsova SM; Glazovskaia II; Kuznetsov VV
    Lik Sprava; 1997; (6):132-4. PubMed ID: 9589957
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effects of Ginkgo biloba extract on functional brain activity.. An assessment of clinical and experimental studies].
    Pidoux B
    Presse Med; 1986 Sep; 15(31):1588-91. PubMed ID: 2947107
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective Potential of Ginkgo biloba in Retinal Diseases.
    Martínez-Solís I; Acero N; Bosch-Morell F; Castillo E; González-Rosende ME; Muñoz-Mingarro D; Ortega T; Sanahuja MA; Villagrasa V
    Planta Med; 2019 Nov; 85(17):1292-1303. PubMed ID: 31266069
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A brief history of EGb 761 and its therapeutic uses.
    DeFeudis FV
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S2-7. PubMed ID: 13130382
    [No Abstract]   [Full Text] [Related]  

  • 58. [The use of memoplant (EGb 761) in clinical practice].
    Kamchatov PR; Chugunov AV; Abusueva BA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):86-90. PubMed ID: 23951579
    [No Abstract]   [Full Text] [Related]  

  • 59. [Neurasthenia as a variant of the asthenic syndrome: a pharmacotherapeutic analysis modelled on tanakan therapy].
    Krasnov VN; Vel'tishev DIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(7):37-40. PubMed ID: 10441850
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tanakan as a multimodal cytoprotective factor in general medicine].
    Naprienko MV; Esin RG; Mukhametova ER; Esin OR; Smekalkina LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(11):146-151. PubMed ID: 27030838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.